-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Mirum Pharmaceuticals, Raises Price Target to $167

Benzinga·11/04/2026 13:47:25
Listen to the news
Citizens analyst Jonathan Wolleben maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Market Outperform and raises the price target from $144 to $167.